vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Paylocity Holding Corp (PCTY). Click either name above to swap in a different company.
Paylocity Holding Corp is the larger business by last-quarter revenue ($387.0M vs $284.0M, roughly 1.4× ACADIA PHARMACEUTICALS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 13.0%, a 83.4% gap on every dollar of revenue. On growth, Paylocity Holding Corp posted the faster year-over-year revenue change (11.3% vs 9.4%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 2.7%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Paylocity Holding Corporation is an American provider of cloud-based payroll, , spend management, and human capital management (HCM) software.
ACAD vs PCTY — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $387.0M |
| Net Profit | $273.6M | $50.2M |
| Gross Margin | 90.8% | 72.9% |
| Operating Margin | 6.1% | 18.2% |
| Net Margin | 96.3% | 13.0% |
| Revenue YoY | 9.4% | 11.3% |
| Net Profit YoY | 90.3% | 34.0% |
| EPS (diluted) | $1.61 | $0.92 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | $387.0M | ||
| Q3 25 | $278.6M | $378.9M | ||
| Q2 25 | $264.6M | $369.9M | ||
| Q1 25 | $244.3M | $421.1M | ||
| Q4 24 | $259.6M | $347.7M | ||
| Q3 24 | $250.4M | $333.1M | ||
| Q2 24 | $242.0M | $324.7M | ||
| Q1 24 | $205.8M | $366.8M |
| Q4 25 | $273.6M | $50.2M | ||
| Q3 25 | $71.8M | $48.0M | ||
| Q2 25 | $26.7M | $48.6M | ||
| Q1 25 | $19.0M | $91.5M | ||
| Q4 24 | $143.7M | $37.5M | ||
| Q3 24 | $32.8M | $49.6M | ||
| Q2 24 | $33.4M | $48.8M | ||
| Q1 24 | $16.6M | $85.3M |
| Q4 25 | 90.8% | 72.9% | ||
| Q3 25 | 92.2% | 73.9% | ||
| Q2 25 | 92.2% | 73.5% | ||
| Q1 25 | 91.7% | 77.1% | ||
| Q4 24 | 91.6% | 72.6% | ||
| Q3 24 | 92.5% | 74.4% | ||
| Q2 24 | 92.5% | 74.0% | ||
| Q1 24 | 88.8% | 77.8% |
| Q4 25 | 6.1% | 18.2% | ||
| Q3 25 | 12.8% | 19.6% | ||
| Q2 25 | 12.2% | 17.9% | ||
| Q1 25 | 7.9% | 30.2% | ||
| Q4 24 | 59.1% | 13.4% | ||
| Q3 24 | 12.6% | 19.3% | ||
| Q2 24 | 12.6% | 19.4% | ||
| Q1 24 | 7.4% | 29.0% |
| Q4 25 | 96.3% | 13.0% | ||
| Q3 25 | 25.8% | 12.7% | ||
| Q2 25 | 10.1% | 13.1% | ||
| Q1 25 | 7.8% | 21.7% | ||
| Q4 24 | 55.4% | 10.8% | ||
| Q3 24 | 13.1% | 14.9% | ||
| Q2 24 | 13.8% | 15.0% | ||
| Q1 24 | 8.0% | 23.3% |
| Q4 25 | $1.61 | $0.92 | ||
| Q3 25 | $0.42 | $0.86 | ||
| Q2 25 | $0.16 | $0.87 | ||
| Q1 25 | $0.11 | $1.61 | ||
| Q4 24 | $0.86 | $0.66 | ||
| Q3 24 | $0.20 | $0.88 | ||
| Q2 24 | $0.20 | $0.85 | ||
| Q1 24 | $0.10 | $1.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $162.5M |
| Total DebtLower is stronger | — | $81.3M |
| Stockholders' EquityBook value | $1.2B | $1.1B |
| Total Assets | $1.6B | $7.0B |
| Debt / EquityLower = less leverage | — | 0.07× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | $162.5M | ||
| Q3 25 | $258.0M | $165.2M | ||
| Q2 25 | $253.6M | $398.1M | ||
| Q1 25 | $217.7M | $477.8M | ||
| Q4 24 | $319.6M | $482.4M | ||
| Q3 24 | $155.1M | $778.5M | ||
| Q2 24 | $177.1M | $401.8M | ||
| Q1 24 | $204.7M | $492.7M |
| Q4 25 | — | $81.3M | ||
| Q3 25 | — | $81.3M | ||
| Q2 25 | — | $162.5M | ||
| Q1 25 | — | $243.8M | ||
| Q4 24 | — | $325.0M | ||
| Q3 24 | — | $325.0M | ||
| Q2 24 | — | $0 | ||
| Q1 24 | — | — |
| Q4 25 | $1.2B | $1.1B | ||
| Q3 25 | $917.3M | $1.1B | ||
| Q2 25 | $822.4M | $1.2B | ||
| Q1 25 | $765.2M | $1.2B | ||
| Q4 24 | $732.8M | $1.2B | ||
| Q3 24 | $577.2M | $1.1B | ||
| Q2 24 | $516.7M | $1.0B | ||
| Q1 24 | $464.0M | $1.1B |
| Q4 25 | $1.6B | $7.0B | ||
| Q3 25 | $1.3B | $4.2B | ||
| Q2 25 | $1.2B | $4.4B | ||
| Q1 25 | $1.1B | $5.2B | ||
| Q4 24 | $1.2B | $5.3B | ||
| Q3 24 | $976.9M | $4.0B | ||
| Q2 24 | $914.1M | $4.2B | ||
| Q1 24 | $855.1M | $5.0B |
| Q4 25 | — | 0.07× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.20× | ||
| Q4 24 | — | 0.28× | ||
| Q3 24 | — | 0.29× | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $117.0M |
| Free Cash FlowOCF − Capex | — | $113.6M |
| FCF MarginFCF / Revenue | — | 29.4% |
| Capex IntensityCapex / Revenue | — | 0.9% |
| Cash ConversionOCF / Net Profit | -0.18× | 2.33× |
| TTM Free Cash FlowTrailing 4 quarters | — | $461.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | $117.0M | ||
| Q3 25 | $74.3M | $86.5M | ||
| Q2 25 | $64.0M | $86.6M | ||
| Q1 25 | $20.3M | $186.0M | ||
| Q4 24 | $40.4M | $54.2M | ||
| Q3 24 | $63.2M | $91.5M | ||
| Q2 24 | $25.0M | $79.9M | ||
| Q1 24 | $29.1M | $167.5M |
| Q4 25 | — | $113.6M | ||
| Q3 25 | $73.9M | $82.7M | ||
| Q2 25 | — | $81.1M | ||
| Q1 25 | — | $183.7M | ||
| Q4 24 | — | $51.2M | ||
| Q3 24 | $63.2M | $89.1M | ||
| Q2 24 | — | $73.6M | ||
| Q1 24 | — | $162.0M |
| Q4 25 | — | 29.4% | ||
| Q3 25 | 26.5% | 21.8% | ||
| Q2 25 | — | 21.9% | ||
| Q1 25 | — | 43.6% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | 25.2% | 26.8% | ||
| Q2 24 | — | 22.7% | ||
| Q1 24 | — | 44.2% |
| Q4 25 | — | 0.9% | ||
| Q3 25 | 0.1% | 1.0% | ||
| Q2 25 | — | 1.5% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | — | 0.9% | ||
| Q3 24 | 0.0% | 0.7% | ||
| Q2 24 | — | 1.9% | ||
| Q1 24 | — | 1.5% |
| Q4 25 | -0.18× | 2.33× | ||
| Q3 25 | 1.03× | 1.80× | ||
| Q2 25 | 2.40× | 1.78× | ||
| Q1 25 | 1.07× | 2.03× | ||
| Q4 24 | 0.28× | 1.45× | ||
| Q3 24 | 1.93× | 1.84× | ||
| Q2 24 | 0.75× | 1.64× | ||
| Q1 24 | 1.76× | 1.96× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
PCTY
| Recurring Fees | $370.1M | 96% |
| Implementation Services And Other | $16.9M | 4% |
